Sensitization to brain antigens after stroke is augmented by lipopolysaccharide

Journal of Cerebral Blood Flow and Metabolism

Volumn 25, Issue 12, 2005, Pages 1634-1644

  Becker, Kyra J ^a,b   Kindrick, Darin L ^a   Lester, Mark P ^a   Shea, Connor ^a   Ye, Zu Cheng ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Immune response; Infection; Inflammation; LPS; Stroke

Indexed keywords

B7 ANTIGEN; BRAIN ANTIGEN; LIPOPOLYSACCHARIDE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SENSITIZATION; STROKE;

ANIMALS; ATROPHY; AUTOANTIGENS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; GRAM-NEGATIVE BACTERIA; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPOPOLYSACCHARIDES; MALE; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW;

EID: 24744435520     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600160     Document Type: Article

References (43)

1. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D'Alessandro R (1995) Fever in acute stroke worsens prognosis. A prospective study. Stroke 26:2040-3
2. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-44
3. Bechmann I, Peter S, Beyer M, Gimsa U, Nitsch R (2001) Presence of B7-2 (CD86) and lack of B7-1 (CD(80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. FASEB J 15:1086-8
4. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R (2003) Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34:1809-15
5. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873-8
6. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6
7. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J (2001) Antibodies to brain antigens following stroke. Neurology 56:529-30
8. Croft M, Dubey C (1997) Accessory molecule and costimulation requirements for CD4 T cell response. Crit Rev Immunol 17:89-118
9. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49:1752-62
10. Dangond F, Windhagen A, Groves CJ, Hafler DA (1997) Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J Neuroimmunol 76:132-8
11. Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, Kelley KW (1998) Molecular basis of sickness behavior. Ann N Y Acad Sci 856:132-8
12. Davenport RJ, Dennis MS, Wellwood I, Warlow CP (1996) Complications after acute stroke. Stroke 27:415-20
13. Di Rosa F, Serafini B, Scognamiglio P, Di Virgilio A, Finocchi L, Aloisi F, Barnaba V (2000) Short-lived immunization site inflammation in self-limited active experimental allergic encephalomyelitis. Int Immunol 12:711-9
14. Enlimomab Acute Stroke Trial Investigators (2001) Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial. Neurology 57:1428-34
15. Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W (1999) Fever and infection early after ischemic stroke. J Neurol Sci 171:115-20
16. Hanisch UK, Neuhaus J, Quirion R, Kettenmann H (1996) Neurotoxicity induced by interleukin-2: involvement of infiltrating immune cells. Synapse 24:104-14
17. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ (2000) Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31:2670-7
18. Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-2
19. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD (2003) Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 34:975-81
20. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, Faught Jr RE, Haley Jr EC (1998) Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 29:447-53
21. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG (2002) Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22:2690-700
22. Kallen B, Nilsson O, Thelin C (1977) Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction. Acta Neurol Scand 55:47-56
23. Kato H, Kogure K, Liu XH, Araki T, Itoyama Y (1996) Progressive expression of immunomolecules on activated microglia and invading leukocytes followingfocal cerebral ischemia in the rat. Brain Res 734:203-12
24. Kissler S, Anderton SM, Wraith DC (2001) Antigen-presenting cell activation: a link between infection and autoimmunity? J Autoimmun 16:303-8
25. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-18
26. Larson SJ, Collins SM, Weingarten HP (1996) Dissociation of temperature changes and anorexia after experimental colitis and LPS administration in rats. Am J Physiol 271:R967-72
27. Li HL, Liu JQ, Bai XF, vn der Meide PH, Link H (1998) Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Immunology 94:431-7
28. Pollak Y, Ovadia H, Goshen I, Gurevich R, Monsa K, Avitsur R, Yirmiya R (2000) Behavioral aspects of experimental autoimmune encephalomyelitis. J Neuroimmunol 104:31-6
29. Popovich PG, Stokes BT, Whitacre CC (1996) Concept of autoimmunity followingspinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res 45:349-63
30. Puri J, Mishra B, Mal A, Murthy NS, Thakur A, Dogra V, Singh D (2002) Catheter associated urinary tract infections in neurology and neurosurgical units. J Infect 44:171-5
31. Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH, Perrin PJ (1995) Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J Clin Invest 96:2195-203
32. Reith J, Jorgensen H, Pedersen P, Nakayama H, Raaschou H, Jeppesen L, Olsen T (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, and mortality. Lancet 347:422-5
33. Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9-18, ; quiz 18, 21
34. Schallert T, Whishaw IQ (1984) Bilateral cutaneous stimulation of the somatosensory system in hemide-corticate rats. Behav Neurosci 98:518-40
35. Singh AK, Jiang Y (2004) How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201:197-207
36. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-3
37. Targoni OS, Baus J, Hofstetter HH, Hesse MD, Karulin AY, Boehm BO, Forsthuber TG, Lehmann PV (2001) Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J Immunol 166:4757-64
38. Touzani O, Boutin H, Chuquet J, Rothwell N (1999) Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 100:203-15
39. Wang WZ, Olsson T, Kostulas V, Hojeberg B, Ekre HP, Link H (1992) Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol 88:157-62
40. Weiner HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207-14
41. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M (1999) Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30:1190-5
42. Youngchaiyud U, Coates AS, Whittingham S, Mackay IR (1974) Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents. Aust N Z J Med 4:535-8
43. Zea-Longa E, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91